Zinc-finger antiviral protein (ZAP) is a restriction factor for replication of modified vaccinia virus Ankara (MVA) in human cells.
Modified vaccinia virus Ankara (MVA) is an approved smallpox vaccine and a promising vaccine vector for other pathogens as well as for cancer therapeutics with more than 200 current or completed clinical trials. MVA was derived by passaging the parental Ankara vaccine virus hundreds of times in chic...
Main Authors: | Chen Peng, Linda S Wyatt, Shira G Glushakow-Smith, Madhu Lal-Nag, Andrea S Weisberg, Bernard Moss |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-08-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1008845 |
Similar Items
-
SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cells.
by: Ruikang Liu, et al.
Published: (2019-05-01) -
A Genotype of Modified Vaccinia Ankara (MVA) that Facilitates Replication in Suspension Cultures in Chemically Defined Medium
by: Volker Sandig, et al.
Published: (2013-01-01) -
TRIM25 Enhances the Antiviral Action of Zinc-Finger Antiviral Protein (ZAP).
by: Melody M H Li, et al.
Published: (2017-01-01) -
The Zinc-Finger Antiviral Protein ZAP Inhibits LINE and Alu Retrotransposition.
by: John B Moldovan, et al.
Published: (2015-05-01) -
KHNYN is essential for the zinc finger antiviral protein (ZAP) to restrict HIV-1 containing clustered CpG dinucleotides
by: Mattia Ficarelli, et al.
Published: (2019-07-01)